| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |